Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
AI and Autonomy Robotic lung biopsy system brings earlier cancer detection closer to patients Lung cancer remains the leading cause of cancer deaths worldwide Joseph MortonJuly 15, 2026
Medical and Pharmaceutical Canadian trial to test blood-based cancer detection in 7,000 survivors SHERLOCK will recruit patients who have already undergone treatments intended to cure their disease Joseph MortonJuly 14, 2026
Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan DunneJune 4, 2026
Medical and Pharmaceutical China’s Westlake University develops palm-sized lung cancer blood test It could surpass current liquid biopsy options after further evaluation Rowan DunneMay 27, 2026
Medical and Pharmaceutical Guardant gets FDA nod for next-gen cancer mutation blood test Milestone builds on firm attaining FDA Breakthrough Device Designation for another liquid biopsy in 2025 Rowan DunneMay 24, 2026
Medical and Pharmaceutical PrognomiQ shares promising early results from novel lung cancer blood test Promising, but the findings are derived from a small study Rowan DunneMay 13, 2026
Medical and Pharmaceutical Medtech company Vitestro pulls US$70M together for autonomous blood draw tech 'Aletta' uses AI and 3D ultrasound guidance for proper placement of a robotic needle Rowan DunneMarch 16, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026